Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 14, 2019 Off

Aspergillosis Infections Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Aspergillosis Infections Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Aspergillosis Infections…

June 14, 2019 Off

Shinkowa Pharmaceutical Co., Ltd. Accelerates Comprehensive NMN Activities, All the Way from Establishing In-House Research Laboratory to Commercialization!

By BusinessWire

We are the company that will achieve productive aging worldwide with advancing biomedical science. TOKYO–(BUSINESS WIRE)–Shinkowa Pharmaceutical Co., Ltd. (Head…

June 14, 2019 Off

Sanfilippo Syndrome Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Sanfilippo Syndrome Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Sanfilippo Syndrome…

June 14, 2019 Off

Hemolytic Uremic Syndrome Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Hemolytic Uremic Syndrome Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Hemolytic…

June 14, 2019 Off

Alpha-1 Antitrypsin Congenital Deficiency Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Alpha-1 Antitrypsin Congenital Deficiency Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering.…

June 14, 2019 Off

IgA Nephropathy Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global IgA Nephropathy Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. IgA Nephropathy…

June 14, 2019 Off

Avian Influenza Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Avian Influenza Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Avian Influenza…

June 14, 2019 Off

Constipation-Predominant Irritable Bowel Syndrome Clinical Trial Pipeline Highlights, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Constipation-Predominant Irritable Bowel Syndrome Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering.…

June 14, 2019 Off

Renal Fibrosis Clinical Trial Pipeline Highlights 2019 – Global Forecast to 2024 by Clinical Trial Stage, Drug Mechanism Class, Company – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Renal Fibrosis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Renal Fibrosis…

June 14, 2019 Off

Morphic Therapeutic Appoints Former Gilead Leader Norbert Bischofberger, Ph.D., to Board of Directors

By BusinessWire

WALTHAM, Mass.–(BUSINESS WIRE)–Morphic Therapeutic, a biotechnology company developing oral integrin therapies, today announced the appointment of former Gilead chief scientific…

Posts pagination

Previous 1 … 3,082 3,083 3,084 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine